Both in Biotechnology
BioCardia vs TScan Therapeutics
Over the past year BCDA returned −31.3% and TCRX returned −81.3%; their daily moves had a correlation of 0.18.
BCDA −31.3% TCRX −81.3%Growth of $1, one year, split-adjusted
| Metric | BCDA | TCRX |
|---|---|---|
| Price | $0.9131 | $0.2100 |
| Market cap | $13.8M | $14.2M |
| Today | −0.92% | +11.11% |
| 1 month | −13.9% | −23.7% |
| 6 months | −17.7% | −83.2% |
| Year to date | −27.0% | −79.0% |
| 1 year | −34.3% | −83.1% |
| Revenue growth (YoY) | — | −65.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −2888.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.0× |
| Net cash | $4.1M | $67.4M |
| Dividend yield | — | — |
| Volatility (60d) | 68.9% | 143.0% |
| Short % of float | 6.2% | 4.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).